Who owns ATHIRA PHARMA INC?
- CUSIP Number: 04746l203
Tip: Access positions for across all investors
Analyze quarterly positions in Athira Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Athira Pharma stock
Who bought or sold ATHIRA PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Perceptive Advisors | 540k | $2.2M | 100% | Sep 2025 |
|
| Acorn Capital Advisors | 502k | $3.8M | 100% | Dec 2025 |
|
| TCG Crossover Management | 464k | $3.3M | 100% | Dec 2025 |
|
| Commodore Capital | 464k | $3.5M | 100% | Dec 2025 |
|
| NEA Management Company | 464k | $3.5M | 100% | Dec 2025 |
|
| ADAR1 Capital Management | 394k | $2.9M | 100% | Dec 2025 |
|
| Vanguard Group | 154k | $1.2M | 0% | Dec 2025 |
|
| Propel Bio Management | 149k | $1.1M | 0% | Dec 2025 |
|
| Simplify Asset Management | 149k | $1.1M | 0% | Dec 2025 |
|
| Seven Fleet Capital Management | 128k | $969k | 100% | Dec 2025 |
|
| Renaissance Technologies | 75k | $569k | 45% | Dec 2025 |
|
| Pathstone Holdings | 39k | $279k | 0% | Dec 2025 |
|
| BlackRock | 38k | $285k | 0% | Dec 2025 |
|
| Acadian Asset Management | 38k | $282k | -7% | Dec 2025 |
|
| Citadel Advisors | 34k | $141k | 100% | Sep 2025 |
|
| Geode Capital Management | 31k | $234k | 1% | Dec 2025 |
|
| Laird Norton Tyee Trust | 22k | $165k | 116% | Dec 2025 |
|
| Susquehanna International | 21k | $159k | 0% | Dec 2025 |
|
| Two Sigma Advisers | 15k | $62k | 100% | Sep 2025 |
|
| Jane Street | 13k | $100k | 100% | Dec 2025 |
|
| State Street Corporation | 11k | $81k | 0% | Dec 2025 |
|
| Northern Trust | 11k | $79k | 100% | Dec 2025 |
|
| Scientech Research | 10k | $77k | 100% | Dec 2025 |
|
| Advisor Group Holdings | 9.2k | $70k | 31% | Dec 2025 |
|
| UBS Group | 3.4k | $26k | 2253% | Dec 2025 |
|
| Tower Research Capital | 379.00 | $2.9k | -41% | Dec 2025 |
|
| American Capital Advisory | 200.00 | $1.5k | 0% | Dec 2025 |
|
| Rothschild Investment | 150.00 | $1.1k | 0% | Dec 2025 |
|
| McIlrath & Eck | 82.00 | $621.002400 | 0% | Dec 2025 |
|
| Us Bancorp | 81.00 | $612.999900 | 0% | Dec 2025 |
|
| Group One Trading | 69.00 | $521.998800 | 100% | Dec 2025 |
|
| Royal Bank of Canada | 67.00 | $0 | 100% | Sep 2025 |
|
| Global Retirement Partners | 52.00 | $393.000400 | 0% | Dec 2025 |
|
| Goss Wealth Management | 50.00 | $378.000000 | 100% | Dec 2025 |
|
| Jones Financial Companies, L.L | 33.00 | $250.001400 | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 23.00 | $173.999600 | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 12.00 | $50.000400 | 100% | Sep 2025 |
|
| SBI Securities | 12.00 | $90.999600 | -45% | Dec 2025 |
|
Who sold out of Athira Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| BML Capital Management | Sep 2025 | 323k | $1.3M |
| Tang Capital Management | Sep 2025 | 60k | $248k |
| Colony | Sep 2025 | 8.4k | $558k |